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Introduction
Cardiovascular implantable electronic devices (CIED) are 
extensively employed for arrhythmia and congestive heart failure.1) 
Simultaneously, there has been an associated increase in rate 
of CIED infections.2) CIED infections, frequently complicated by 
formation of vegetations on the intracardiac aspect of the leads 
and adjoining structures, including valvular leaflets, are associated 
with significant morbidity and mortality.3)4) In every single patient 
with CIED infections, complete device and lead removal with 
antimicrobial therapy is recommended.5) However, the extraction of 
chronically implanted transvenous lead systems remains a complex 
procedure and is associated with considerable morbidity and 
mortality.6) Sometimes, there is fragmentation of leads which leads 
to failure of extraction of all of pacing leads.7) The fate of remnant 
lead materials is still controversial. A study8) suggested that the 
extraction of an entire lead might not be necessary, if the lead could 
be totally separated from an infected pocket. Meanwhile, several 
studies reported that the intracardiac portion of a lead might be 
colonized even in cases limited to localized pocket infections.9-11) In 
addition to the aspect of CIED infections, remnant lead fragments 
may cause mechanical complications such as embolization into 
the pulmonary arterial bed.7)12) This report describes cases of five 
patients with remnant lead tips after lead extraction for CIED 
infections and managed only by administration of antibiotics. This 
study was approved by the Institutional Review Board of Yonsei 
University Hospital.
Case
Among 86 patients, who underwent lead removals for CIED 
infections between January 2000 to June 2015, a transvenous and 
a surgical lead removal was performed in 84 (98%) and two (2%) 
patients, respectively. Five patients had remnant lead tips (Fig. 1). 
The clinical features of these five patients are described below. 
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Patients with localized pocket infections
Case 1
A 93-year-old female was admitted for skin erosion at the 
site of the generator pocket (Patient 1 in Table 1-1). The patient 
had undergone a permanent dual chamber (DDD) pacemaker 
implantation 10 years back for symptomatic sick sinus syndrome.
There was no evidence of a systemic infection. The patient 
underwent a transvenous lead removal initially using the direct 
traction and traction/counter-traction method with a locking 
stylet. The lead tip separated from the right ventricle (RV) lead 
during the extraction procedure (Patient 1 in Table 1-2). Two weeks 
after the extraction, the remnant RV lead tip embolized into the 
right middle pulmonary artery (Fig. 2A). There was no evidence of a 
pulmonary infarction or infection. During a 4-year follow up study, 
no adverse events were reported.
Case 2
A 43-year-old male was referred for the left-sided generator 
exposure (Patient 2 in Table 1-1). The patient had Eisenmenger 
syndrome and right heart failure. The patient had undergone a DDD 
pacemaker implantation 31 years back for complete atrioventricular 
block, via the left subclavian vein. Due to a lead fracture of left 
sided DDD pacemaker, an atrial synchronous, ventricular demand 
(VDD) pacemaker was newly implanted via the right subclavian vein 
10 years back. He was treated with oral antibiotics at the referring 
hospital for a week.
We tried a transvenous lead extraction of the DDD pacemaker. 
The left sided RV lead was separated at the middle part, and almost 
10 cm of the RV lead was still present. To remove the remaining 
lead, transfemoral traction with a snare was used (Patient 2 in 
Table 1-2). However, we failed to remove the tip of the RV lead (Fig. 
2B). Because of the unstable condition due to severe pulmonary 
hypertension, the procedure was terminated. The patient did not 
show any further evidence of infection and we decided to maintain 
the right sided VDD pacemaker. During 23-months of follow up, 
the patient has shown no evidence of infection or complications.
Patients with systemic infections
Case 3
A 77-year-old male was admitted for fever (Patient 3 in Table 
1-1). The patient had undergone a DDD pacemaker implantation 
18 years back for complete atrioventricular block. Transthoracic 
echocardiogram (TTE) revealed multiple vegetations (2.0 cm 
maximum) attached to the RV lead. The patient initially underwent 
a surgical lead extraction, considering large vegetations. The RV 
lead was not completely removed because of severe adhesion to 
the leaflet and chordae of the tricuspid valve. The proximal part 
of remaining RV lead in the left subclavian vein was removed by a 
transvenous approach (Patient 3 in Table 1-2). However, the tip of 
RV lead was left behind (Fig. 2C). A new pacemaker was implanted 
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Fig. 1. Diagram representing the patients. CIED: cardiovascular implantable 
electronic device.
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Fig. 2. Chest radiographs of four patients. (A) Embolization of the remnant 
lead tip (arrow) after lead extraction in Patient 1. (B) The remaining lead tip 
(arrow) after lead extraction in Patient 2. (C) The remnant lead tip (arrow) 
after lead extraction in Patient 3. A new pacemaker was implanted on the 
contralateral side. (D) The remnant lead tip (arrow) after lead extraction in 
Patient 4. A new epicardial pacemaker was implanted.
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via the right subclavian vein 14 days after the device removal 
(18 days after the blood cultures were confirmed to be negative). 
During 26-months of follow up, the patient has shown no evidence 
of infection or complications.
Case 4
A 69-year-old male was admitted for fever and chills (Patient 4 in Table 
1-1). The patient had undergone a VDD pacemaker implantation 8 years 
back for symptomatic tachy-brady syndrome. TTE revealed vegetation 
(0.9x0.6 cm) attached to the right atrium (RA) lead and severe tricuspid 
regurgitation (TR). The patient had to undergo a surgical lead extraction 
for simultaneous surgical correction of severe TR. The VDD lead was 
not completely removed because of severe adhesion to the chordae 
of the tricuspid valve. The proximal part of remaining VDD lead in the 
left subclavian vein was removed by a transvenous approach via the 
left subclavian vein (Patient 4 in Table 1-2). However, the VDD lead tip 
was still left behind (Fig. 2D). A pacemaker was implanted epicardially 
at the time of the initial surgical removal. There was no evidence of 
any resurgence of the infection after the completion of the antibiotic 
therapy, at the 36-months follow up.
Table 1-1. Baseline characteristics and clinical manifestation
Patients Sex Age (years)
Type of 
device
Indication
for the device
Lead type Duration(years)
Type of
infection Organism
Echocardiography
findings
1 Female 93 PPM (DDD) SSS
 A-screw, 
V-tined
10 
Localized 
Pocket 
infection
Staphylococcus, 
coagulase negative
(wound culture)
None remarkable
2
Male
43 PPM (DDD) CAVB
 A-screw (left),
V-screw (left)
VDD (right)
31 (left),
10 (right)
Localized 
Pocket 
infection
No organisms 
grown
None remarkable
3
Male
77 PPM (DDD) CAVB
 A-tined,
V-tined
18 
Systemic 
infection
MSSA (blood, 
wound culture)
Multiple vegetations 
(2.0 cm maximum) on the 
RV lead
4
Male
69 PPM (VDD) TBS VDD lead 8 
Systemic 
infection
No organisms 
grown
Vegetation (0.9x0.6 cm) on 
the RA lead
5
Female
54 PPM (VVI) CAVB
 V-tined (left), 
V-tined (right)
11 (left)
22 (right)
Systemic 
infection
No organisms 
grown
Multiple vegetations 
(2.3 cm, 1.5 cm, 0.6 cm) on 
TV and IAS on the RA side
PPM: permanent pacemaker, DDD: dual chamber pacing, SSS: sick sinus syndrome, CAVB: complete atrioventricular block, VDD: atrial synchronous, ventricular 
demand pacing, TBS: tachy-brady syndrome, VVI: ventricular demand pacing, MSSA: methicillin-susceptible Staphylococcus aureus, RV: right ventricle, 
RA: right atrium, TV: tricuspid valve, IAS: interatrial septum
Table 1-2. Treatment and follow-up
Patients ExtractionMethod
Retained lead: 
site Antibiotics
Duration of the 
antibiotic treatment
(IV/total days)
Day of the 
reimplantation 
(days after extraction)
FU
(months)
1 DT/CT with a locking stylet
V lead tip: 
TV annulus
TEI
→ PO CFX
14/29 - 48
2
DT/CT with a locking stylet:
Transfemoral traction with a snare kit
V lead tip: 
RV apex
VAN
→ PO AMP/SUL
8/14
- 
(maintain the right sided 
VDD lead)
23
3
Surgical removal:
DT/CT with a locking stylet*
V lead tip: 
RV apex
VAN-GEN-RIF
→ NAF
43/43 14 26
4
Surgical removal:
DT/CT with a locking stylet*
V lead tip: 
RV
TEI-LFX
→ PO AMP/SUL
29/36 0 36
5
DT/CT with a locking stylet: 
Transfemoral traction with a snare kit
V lead tip: 
RV apex
VAN-RIF
→ ARB
41/41 85 5
*These 2 patients underwent surgery for the lead removal initially: but the atrial and ventricular leads could not be removed: and decision was made to perform 
a secondary lead removal via a transvenous approach. IV: intravenous, FU: follow up, DT: direct traction, CT: counter traction, V: ventricle, TV: tricuspid valve, 
RV: right ventricle, TEI: teicoplanin, PO: per os, CFX: cefixime, VAN: vancomycin, AMP/SUL: ampicillin/sulbactam, GEN: gentamycin, RIF: rifampin, NAF: nafcillin, 
LFX: levofloxacin, ARB: arbekacin
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Case 5
A 54-year-old female was admitted due to continuous fever 
for a month (Patient 5 in Table 1-1). The patient had undergone 
a ventricular demand pacing (VVI) pacemaker implantation for 
complete atrioventricular block via the right subclavian vein 22 
years back. Eleven years after initial implantation, the right-sided 
generator was removed for the generator exposure and a new VVI 
pacemaker was implanted via the left subclavian vein (Fig. 3A). At the 
time of admission, transesophageal echocardiogram (TEE) showed 
multiple and large (2.3 cm maximum) vegetations attached to the 
pacemaker leads, septum, and tricuspid valve. We tried to remove 
the pacemaker leads by the traction/countertraction method with 
a locking stylet. The left sided pacemaker lead was completely 
removed. The ventricular lead of the right sided pacemaker was 
fractured and removed by a transfemoral traction method with 
the aid of a snare kit (Patient 5 in Table 1-2). Unfortunately, the 
ventricular lead tip fragmented off and was left behind in the 
RV apex (Fig. 3B). A new VVI pacemaker was implanted three 
months after the lead extraction (Fig. 3C). A month after the 
new pacemaker implantation, the patient was admitted for fever. 
TEE showed presence of a new vegetation attached to the newly 
implanted lead. The vegetation and the lead were removed by open 
heart surgery, and an epicardial pacemaker was newly implanted 
(Fig. 3D). 
Discussion
Because of the concerns over colonization and the higher risk 
of recurrence, the mainstay of CIED infection management has 
been established as the complete removal of the entire implanted 
device system in patients with device-related endocarditis, and also 
with only localized pocket infections.13-15) Although the extraction 
procedure has matured into a defined art, the physicians still 
fail to remove all the components of an implanted system by 
the transvenous approach and even by the surgical approach. 
In patients with pocket infections, Love et al.8) reported that 
extraction of an entire lead might not be necessary if the lead 
could be totally separated from an infected pocket. Also, a case 
of curing the infection through antibiotic administration alone has 
been reported.16) However, the outcomes and optimal management 
of device-related endocarditis with retained material have not been 
elucidated. We experienced cases of two locally infected patients 
and three endocarditis patients with retained lead fragments after 
the device removal. All the remaining parts of their devices were 
RV lead tips. Considering that most CIED infections are due to 
staphylococcal species and some of the species would be methicillin 
resistant, vancomycin (Patients 2, 3, and 5) and teicoplanin (Patients 
1 and 4), were administered to the patients as initial empirical 
antibiotics until the culture results were revealed. In the patients 
whose infections were limited to the pocket site (Patients 1 and 
2); we continued the antibiotic treatment for over seven days with 
parenteral agents and for a total of 14 days. In patients with systemic 
infections, we continued the parenteral antibiotic therapy for at 
least 4 weeks. Neither locally infected patients nor systemically 
infected patients experienced any relapse of the infection during a 
median of 26-month follow up (range 5-48 months). For the CIED 
infection, in cases with remaining fragmented lead tips, we suggest 
that a conservative management with a sufficiently long, proper 
antibiotic treatment can be considered.
Only 1 out of 5 patients (Patient 1) had complications caused 
due to retaining material in our series. Development of pulmonary 
embolization of the remnant lead tip occurred, but there was no 
evidence of infection or pulmonary infarction, and the patient did not 
undergo any additional treatment during 48-months of follow-up.
Three patients (Patients 3, 4, and 5) underwent new pacemaker 
reimplantations and all those patients had systemic infections 
initially. Two patients showed no relapse of infections or other 
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Fig. 3. Chest radiographs of patient 5. (A) The lead of the right sided 
pacemaker (generator removed previously): and the left sided VVI 
pacemaker. (B) The remnant lead tip (arrow) after lead extraction. (C) The 
remnant lead tip (arrow) and the VVI pacemaker implanted three months 
after lead extraction. (D) The newly implanted epicardial pacemaker after 
surgical removal. VVI: ventricular demand pacing.
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complications after the reimplantation, suggesting that the 
remaining lead fragments were not an absolute contraindication 
for the implantation of a new intracardiac device. However, 
Patient 5 had relapsing fever a month after implantation of a new 
pacemaker. The patient had to undergo open heart surgery for 
complete removal of the remnant lead.
In conclusion, in the case of patients with remnant lead tips after 
a hardware removal for a CIED infection and with device-related 
endocarditis, conservative treatment with antibiotics without the 
retrieval of material can be a safe and effective way. One of five 
patients with retained lead tips in our series experienced pulmonary 
embolism, but neither there was an evidence of an infection nor 
occurrence of pulmonary infarction. Only one of five patients 
experienced resurgence of an infection. 
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